<DOC>
	<DOCNO>NCT00398866</DOCNO>
	<brief_summary>Hyaluronan man-made preparation protein complex occur naturally joint often low people osteoarthritis . Although hyaluronan use million people knee osteoarthritis , yet FDA approve use thumb . The purpose study determine safety effectiveness hyaluronan relieve arthritis symptom base thumb compare corticosteroid local anesthetic . The principle hypothesis treat osteoarthritis carpometacarpophalangeal ( CMC ) joint injectable hyaluronan result great pain relief , high patient satisfaction , good functional outcome treat placebo injection ( local anesthetic ) corticosteroid injection . Treating CMC osteoarthritis corticosteroid injection result great pain relief , high patient satisfaction , good functional outcome treat placebo injection . Patients bad pre-treatment function less improvement bad post-treatment result administration corticosteroid hyaluronan .</brief_summary>
	<brief_title>A Study Hyaluronan Treatment Osteoarthritis Thumb</brief_title>
	<detailed_description>Osteoarthritis involve wear cartilage within joint . It affect joint body , commonly affect joint hand , hip , knee , spine . Over last year , new medicine call hyaluronan use treat osteoarthritis . Hyaluronan man-made preparation protein complex occur naturally joint often low people osteoarthritis . Although hyaluronan use million people knee osteoarthritis , yet FDA approve use thumb . The purpose study determine safety effectiveness hyaluronan relieve arthritis symptom base thumb compare corticosteroid local anesthetic . Specifically , study evaluate pain relief , patient satisfaction , functional outcome among participant . Participation study last 26 week . Screening include questionnaire x-ray affected thumb . Eligible participant randomly assign one three treatment : two hyaluronan injection , one corticosteroid injection plus one local anesthetic injection , two local anesthetic injection . Participants receive injection base thumb , first injection follow second injection week later . There five study visit occur baseline Weeks 2 , 4 , 12 , 26 . All study visit include questionnaire , except Week 2 study visit , also include examination evaluation affect thumb . Photographs thumb take baseline . The injection occur baseline Week 2 . At Weeks 8 20 , questionnaire mail participant complete . Upon complete study , participant option receive continue treatment another round hyaluronic injection .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Presence osteophytes sclerosis carpometacarpal ( CMC ) joint Complaint unacceptable pain despite modification activity therapeutic dose nonsteroidal antiinflammatory drug ( NSAIDS ) , tolerate If bilateral disease , severely involved hand ( define visual analog scale [ VAS ] pain ) enter study Able follow instruction complete questionnaire Failed conservative therapy NSAIDS COX2 inhibitor Unable tolerate COX2 inhibitor Previous traumatic dislocation , ligament tear , fracture thumb affect hand Previous hand surgery affect hand Known hand comorbidities ( e.g. , active carpal tunnel syndrome , de Quervains tenosynovitis , etc . ) Systemic rheumatic disease Bleeding diatheses anticoagulation Allergies steroid , chicken product , bupivicaine , adhesive ( e.g. , doublesided tape ) Current use oral intravenous steroid Active systemic malignancy Hyaluronan injection target CMC joint last 6 month Steroid hyaluronan injection joint last 6 month Insulin dependent diabetes mellitus ( IDDM ) Active infection Pain index joint 40 100 VAS Pain scale End Stage CMC osteoarthritis , equivalent bone bone , Kellgren Lawrence Stage IV Grade 3 4 Eaton Litter ( E+L ) Classification E+L 3 : Advanced joint distraction , subchondral cyst , sclerosis E+L 4 : Involvement several joint surface</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hyaluronan</keyword>
	<keyword>Carpometacarpal</keyword>
	<keyword>Outcomes</keyword>
	<keyword>Carpometacarpal Joints</keyword>
</DOC>